1976. The accident in SEVESO, in ITALY, was the event that marked the awareness of the importance of Health and Environmental Protection among citizens. For twenty years it led to the collaboration of various private and institutional Scientific Working Groups, among which the main one was born at the “Mario Negri” Institute of Pharmacological Research1linked to the discovery of Dioxin contamination. Since the eighties, the scientific and organizational evolution related to the experimental activities carried out by the Applied Research Working Group for Ecological Studies, in the meantime established within the Laboratory of “Environment and Health Research” of IMN, has highlighted a particularly synergistic progressive development path from 1997 to today: the activities, initially focused on Industrial Hygiene and Environmental Monitoring, have evolved towards Computational and Experimental Toxicology, to finally arrive at Integrated Environmental and Health Impact Assessments.2
2000 – Among other things, the Department of Environmental and Health Research was established, which for twenty years operated within the scope of Industrial and Environmental Hygiene Assessments, internalizing all relevant and complementary scientific activities (experimental chemical-physical monitoring, diffusion physical modeling); ensuring respect for the values of independence and rigor of the scientific method.
2013 -The IMN Institute has been recognized as an IRCCS (Scientific Institute for Research, Hospitalization and Treatment) for the pharmacology and clinical trials of neurological, rare, and environmental diseases.
2020 – Significant technological developments and the adoption of accreditation procedures have led to a general improvement in scientific services offered by private companies, including those certified by ACCREDIA. This context, in the post-COVID period, has led the IMN to reorganize and optimize its operational structures, introducing the possibility of coordinated technical and scientific collaboration between INTERCOMPANY Working Groups, provided they share the IRFMN’s values and ethical principles.
2023 – At the end of 2022, a business network was formed in Milan from the passion of a group of professionals and the philanthropic initiative of several companies, already members of inter-company working groups with IMN3, who decided to contribute to protecting our common future and the planet. The network operates within their respective areas of expertise, with particular focus on Environmental and Health Impact Assessments.
- 1961 – A Scientific Foundation operating in the field of Biomedical Research was established and began operations at its Milan headquarters on February 1, 1963. The Mario Negri Institute for Pharmacological Research was directed by Professor Silvio Garattini until June 2018, and is currently directed by Professor Giuseppe Remuzzi. The Institute’s fundamental purpose is to contribute to the defense of public health and human life. ↩︎
- Riepilogo a cura di: Marco Lodi, socio cofondatore e presidente di una società cooperativa (ECOLAB s.c.r.l.) dove ha acquisito le competenze di Igiene Industriale. Successivamente ha fondato una società a responsabilità limitata (AMBIO s.r.l.), dove ha acquisito le competenze di Igiene Ambientale. Per vent’anni è stato Capo Unità d’Igiene Industriale ed Ambientale del Laboratorio di Chimica e Tossicologia dell’Ambiente, Dipartimento Ambiente e Salute dell’Istituto di Ricerche Farmacologiche “Mario Negri” dove ha acquisito le competenze di Tossicologia Ambientale.
Dal 2023 è general manager della Rete d’Impresa NoProfit #Ecologja crsg e come Senior Advisor d’Igiene Industriale e Tossicologia Ambientale è referente del GdL.VIIAS.IMN.UNINS#Ecologja. ↩︎ - storico lavori GdL.IMN.INTERAZIENDALI ↩︎